UAB "LEVIPHARM" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
5,010 |
5,010 |
1,613 |
1,556 |
1,556 |
100.00 |
31.06 |
6,034 |
342 |
0 |
6,376 |
2022 |
---|
2,540 |
2,540 |
957 |
-957 |
-957 |
-41.97 |
-37.68 |
5,077 |
540 |
0 |
5,617 |
2023 |
---|
4,230 |
4,230 |
1 |
-1 |
-1 |
34.54 |
-0.02 |
5,077 |
1,603 |
0 |
6,680 |
Register and
explore Okredo data2023 |
---|
4,230 |
4,230 |
1 |
-1 |
-1 |
34.54 |
-0.02 |
5,077 |
1,603 |
0 |
6,680 |
Register and
explore Okredo data2023
Turnover (€)
4,230 €67 % *
Sales per employee (€)
4,230 €67 % *
Profit before tax (€)
1 €-100 % *
Net Profit (€)
-1 €100 % *
Profit per employee (€)
-1 €100 % *
Total profitability (%)
34.54 %182.30 % *
Net profitability (%)
-0.02 %99.95 % *
Equity (€)
5,077 €0 % *
Amounts Payable And Liabilities (€)
1,603 €197 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
6,680 €19 % *